Low-dose Interleukin-2 Administered Pre-operatively to Patients with Gastric Cancer Activates Peripheral and Peritumoral Lymphocytes But Does Not Affect Prognosis

By Cesana Giovanni   Romano Fabrizio   Piacentini Gaia   Scotti Marco   Brenna Ambrogio   Bovo Giorgio   Vaghi Massimo   Aletti Giacomo   Caprotti Roberto   Kaufman Howard   Uggeri Franco  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1295-1304

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with nonsmall cell lung cancer

By        

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1682-1686

Spandidos Publications

Access to resources Recommend Favorite

Interleukin-12 in Early or Advanced Cancer Patients

By Lissoni P.   Rovelli F.   Pittalis S.   Casati M.   Perego M.S.   Grassi M.G.   Brivio F.   Fumagalli L.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1703-1705

Elsevier

Access to resources Recommend Favorite

Tumor-Infiltrating Lymphocytes Contain Higher Numbers of Type 1 Cytokine Expressors and DR+ T Cells Compared with Lymphocytes from Tumor Draining Lymph Nodes and Peripheral Blood in Patients with Cancer of the Uterine Cervix

By Santin A.D.   Ravaggi A.   Bellone S.   Pecorelli S.   Cannon M.   Parham G.P.   Hermonat P.L.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 424-432

Elsevier

Access to resources Recommend Favorite

Skewed T-helper (Th)1/2- and Th17/T regulatorycell balances in patients with renal cell carcinoma

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 947-953

Spandidos Publications

Access to resources Recommend Favorite